Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

The overall effect of parental supply of alcohol across adolescence on alcohol-related harms in early adulthood - a prospective cohort study.

Clare PJ, Dobbins T, Bruno R, Peacock A, Boland V, Yuen WS, Aiken A, Degenhardt L, Kypri K, Slade T, Hutchinson D, Najman JM, McBride N, Horwood J, McCambridge J, Mattick RP.

Addiction. 2020 Feb 7. doi: 10.1111/add.15005. [Epub ahead of print]

PMID:
32034841
2.

Factors Associated with Alcohol-Related Injuries for Aboriginal and Non-Aboriginal Australians: An Observational Study.

Snijder M, Calabria B, Dobbins T, Shakeshaft A.

Int J Environ Res Public Health. 2020 Jan 7;17(2). pii: E387. doi: 10.3390/ijerph17020387.

3.

Comparative use of cancer therapies in Australian farm, rural nonfarm and urban residents aged 45 years and older.

Depczynski J, Dobbins T, Armstrong B, Lower T.

Public Health Res Pract. 2019 Dec 4;29(4). pii: 28341811. doi: 10.17061/phrp28341811.

4.

Supporting Aboriginal Community Controlled Health Services to deliver alcohol care: protocol for a cluster randomised controlled trial.

Harrison KH, Lee KK, Dobbins T, Wilson S, Hayman N, Ivers R, Haber PS, Conigrave JH, Johnson D, Hummerston B, Gray D, Conigrave K.

BMJ Open. 2019 Nov 10;9(11):e030909. doi: 10.1136/bmjopen-2019-030909.

5.

Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia.

Jones NR, Shanahan M, Dobbins T, Degenhardt L, Montebello M, Gisev N, Larney S.

Drug Alcohol Rev. 2019 Sep;38(6):690-698. doi: 10.1111/dar.12976.

PMID:
31577058
6.

Protocol for the Data-Linkage Alcohol Cohort Study (DACS): investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data.

Peacock A, Chiu V, Leung J, Dobbins T, Larney S, Gisev N, Pearson SA, Degenhardt L.

BMJ Open. 2019 Aug 5;9(8):e030605. doi: 10.1136/bmjopen-2019-030605.

7.

Towards an African Light Source.

Connell SH, Mtingwa SK, Dobbins T, Khumbah N, Masara B, Mitchell EP, Norris L, Ngabonziza P, Ntsoane T, Winick H.

Biophys Rev. 2019 Aug;11(4):499-507. doi: 10.1007/s12551-019-00578-3. Epub 2019 Jul 12. No abstract available.

8.

The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study.

Gisev N, Bharat C, Larney S, Dobbins T, Weatherburn D, Hickman M, Farrell M, Degenhardt L.

Lancet Public Health. 2019 Jul;4(7):e334-e342. doi: 10.1016/S2468-2667(19)30060-X. Epub 2019 Jun 11.

9.

Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP).

Vajdic CM, Perez-Concha O, Rhee JJ, Dobbins T, Ward RL, Schaffer AL, van Leeuwen MT, Laaksonen MA, Craigen G, Pearson SA.

Cancer Epidemiol. 2019 Aug;61:1-7. doi: 10.1016/j.canep.2019.05.001. Epub 2019 May 10.

PMID:
31082704
10.

Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP).

Vajdic CM, Perez-Concha O, Dobbins T, Ward RL, Schaffer AL, van Leeuwen MT, Rhee JJ, Laaksonen MA, Craigen G, Pearson SA.

Cancer Epidemiol. 2019 Jun;60:156-161. doi: 10.1016/j.canep.2019.04.004. Epub 2019 Apr 20.

PMID:
31015097
11.

A cluster randomized controlled trial of an online psychoeducational intervention for people with a family history of depression.

Mills L, Meiser B, Ahmad R, Schofield PR, Peate M, Levitan C, Trevena L, Barlow-Stewart K, Dobbins T, Christensen H, Sherman KA, Dunlop K, Mitchell PB.

BMC Psychiatry. 2019 Jan 17;19(1):29. doi: 10.1186/s12888-018-1994-2.

12.

Combating escalating harms associated with pharmaceutical opioid use in Australia: the POPPY II study protocol.

Gisev N, Pearson SA, Dobbins T, Currow DC, Blyth F, Larney S, Dunlop A, Mattick RP, Wilson A, Degenhardt L.

BMJ Open. 2018 Dec 4;8(12):e025840. doi: 10.1136/bmjopen-2018-025840.

13.

Causal models adjusting for time-varying confounding-a systematic review of the literature.

Clare PJ, Dobbins TA, Mattick RP.

Int J Epidemiol. 2019 Feb 1;48(1):254-265. doi: 10.1093/ije/dyy218.

PMID:
30358847
14.

Brief intervention on Smoking, Nutrition, Alcohol and Physical (SNAP) inactivity for smoking relapse prevention after release from smoke-free prisons: a study protocol for a multicentre, investigator-blinded, randomised controlled trial.

Jin X, Kinner SA, Hopkins R, Stockings E, Courtney RJ, Shakeshaft A, Petrie D, Dobbins T, Dolan K.

BMJ Open. 2018 Oct 18;8(10):e021326. doi: 10.1136/bmjopen-2017-021326.

15.

Cannabis use and non-cancer chronic pain - Authors' reply.

Campbell G, Hall W, Degenhardt L, Dobbins T, Farrell M.

Lancet Public Health. 2018 Oct;3(10):e469. doi: 10.1016/S2468-2667(18)30182-8. No abstract available.

16.

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study.

Larney S, Hickman M, Fiellin DA, Dobbins T, Nielsen S, Jones NR, Mattick RP, Ali R, Degenhardt L.

BMJ Open. 2018 Aug 5;8(8):e025204. doi: 10.1136/bmjopen-2018-025204.

17.

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.

Campbell G, Hall WD, Peacock A, Lintzeris N, Bruno R, Larance B, Nielsen S, Cohen M, Chan G, Mattick RP, Blyth F, Shanahan M, Dobbins T, Farrell M, Degenhardt L.

Lancet Public Health. 2018 Jul;3(7):e341-e350. doi: 10.1016/S2468-2667(18)30110-5.

18.

A Need for Tailored Programs and Policies to Reduce Rates of Alcohol-related Crimes for Vulnerable Communities and Young People: An Analysis of Routinely Collected Police Data.

Snijder M, Calabria B, Dobbins T, Knight A, Shakeshaft A.

Alcohol Alcohol. 2018 Sep 1;53(5):578-585. doi: 10.1093/alcalc/agy034.

PMID:
29846496
19.

Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia.

Schaffer AL, Buckley NA, Degenhardt L, Larance B, Cairns R, Dobbins TA, Pearson SA.

CMAJ. 2018 Mar 26;190(12):E355-E362. doi: 10.1503/cmaj.170666.

20.

The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis.

Brett J, Schaffer A, Dobbins T, Buckley NA, Pearson SA.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):439-446. doi: 10.1002/pds.4408. Epub 2018 Feb 28.

PMID:
29493050
21.

The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study.

Larance B, Dobbins T, Peacock A, Ali R, Bruno R, Lintzeris N, Farrell M, Degenhardt L.

Lancet Psychiatry. 2018 Feb;5(2):155-166. doi: 10.1016/S2215-0366(18)30003-8. Epub 2018 Jan 11.

PMID:
29336948
22.

Comparison of cancer incidence in Australian farm residents 45 years and over, compared to rural non-farm and urban residents - a data linkage study.

Depczynski J, Dobbins T, Armstrong B, Lower T.

BMC Cancer. 2018 Jan 5;18(1):33. doi: 10.1186/s12885-017-3912-2.

23.

Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014).

Daniels B, Kiely BE, Houssami N, Lord SJ, Dobbins T, Lu CY, Ward RL, Pearson SA.

Br J Cancer. 2018 Feb 6;118(3):441-447. doi: 10.1038/bjc.2017.405. Epub 2017 Nov 14.

24.

Stage of diagnosis of prostate, breast and colorectal cancer in farm residents compared with other rural and urban residents in New South Wales.

Depczynski J, Dobbins T, Armstrong B, Lower T.

Aust J Rural Health. 2018 Feb;26(1):56-62. doi: 10.1111/ajr.12392. Epub 2017 Nov 13.

PMID:
29131425
25.

High-dose immunosuppression to prevent death after paraquat self-poisoning - a randomised controlled trial.

Gawarammana I, Buckley NA, Mohamed F, Naser K, Jeganathan K, Ariyananada PL, Wunnapuk K, Dobbins TA, Tomenson JA, Wilks MF, Eddleston M, Dawson AH.

Clin Toxicol (Phila). 2018 Jul;56(7):633-639. doi: 10.1080/15563650.2017.1394465. Epub 2017 Nov 3.

PMID:
29098875
26.

To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?

Gisev N, Pearson SA, Karanges EA, Larance B, Buckley NA, Larney S, Dobbins T, Blanch B, Degenhardt L.

Pharmacoepidemiol Drug Saf. 2018 May;27(5):550-555. doi: 10.1002/pds.4329. Epub 2017 Oct 19.

PMID:
29047196
27.

A motional Stark effect diagnostic analysis routine for improved resolution of iota in the core of the large helical device.

Dobbins TJ, Ida K, Suzuki C, Yoshinuma M, Kobayashi T, Suzuki Y, Yoshida M.

Rev Sci Instrum. 2017 Sep;88(9):093518. doi: 10.1063/1.4995808.

PMID:
28964229
28.

Escalating patterns of emergency health care prior to first admission with amphetamine psychosis: A window of opportunity?

Sara G, Lappin J, Dobbins T, Dunlop AJ, Degenhardt L.

Drug Alcohol Depend. 2017 Nov 1;180:171-177. doi: 10.1016/j.drugalcdep.2017.08.009. Epub 2017 Sep 6.

PMID:
28903079
29.

Trends in heroin and pharmaceutical opioid overdose deaths in Australia.

Roxburgh A, Hall WD, Dobbins T, Gisev N, Burns L, Pearson S, Degenhardt L.

Drug Alcohol Depend. 2017 Oct 1;179:291-298. doi: 10.1016/j.drugalcdep.2017.07.018. Epub 2017 Aug 14.

PMID:
28826104
30.

Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre.

Roxburgh A, Darke S, Salmon AM, Dobbins T, Jauncey M.

Drug Alcohol Depend. 2017 Jul 1;176:126-132. doi: 10.1016/j.drugalcdep.2017.02.027. Epub 2017 May 17.

PMID:
28535454
31.

Prescription Opioid Access Patterns and Factors Associated with Increasing Number of Prescribers, Pharmacies, and Dispensings: An Observational Study Using Pharmaceutical Claims.

Blanch B, Degenhardt L, Buckley NA, Gisev N, Dobbins T, Karanges EA, Larance B, Larney S, Pearson SA.

Pain Med. 2018 Jun 1;19(6):1170-1183. doi: 10.1093/pm/pnx035.

PMID:
28402570
32.

Body mass index trajectories of Indigenous Australian children and relation to screen time, diet, and demographic factors.

Thurber KA, Dobbins T, Neeman T, Banwell C, Banks E.

Obesity (Silver Spring). 2017 Apr;25(4):747-756. doi: 10.1002/oby.21783.

33.

The recovery of online drug markets following law enforcement and other disruptions.

Van Buskirk J, Bruno R, Dobbins T, Breen C, Burns L, Naicker S, Roxburgh A.

Drug Alcohol Depend. 2017 Apr 1;173:159-162. doi: 10.1016/j.drugalcdep.2017.01.004. Epub 2017 Feb 20.

PMID:
28259089
34.

First examination of varying health outcomes of the chronically homeless according to Housing First configuration.

Whittaker E, Dobbins T, Swift W, Flatau P, Burns L.

Aust N Z J Public Health. 2017 Jun;41(3):306-308. doi: 10.1111/1753-6405.12631. Epub 2017 Jan 22.

35.

Relationship between prescribed psychotropic medications and co-ingested alcohol in intentional self-poisonings.

Chitty KM, Dobbins T, Dawson AH, Isbister GK, Buckley NA.

Br J Psychiatry. 2017 Mar;210(3):203-208. doi: 10.1192/bjp.bp.115.172213. Epub 2017 Jan 19.

PMID:
28104739
36.

A synthetic diagnostic for beam emission spectroscopy in the helically symmetric experiment stellarator.

Dobbins TJ, Kumar ST, Anderson DT.

Rev Sci Instrum. 2016 Nov;87(11):11D413.

PMID:
27910621
37.

Understanding barriers to fruit and vegetable intake in the Australian Longitudinal Study of Indigenous Children: a mixed-methods approach.

Thurber KA, Banwell C, Neeman T, Dobbins T, Pescud M, Lovett R, Banks E.

Public Health Nutr. 2017 Apr;20(5):832-847. doi: 10.1017/S1368980016003013. Epub 2016 Nov 29.

38.

Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population.

Lappin JM, Roxburgh A, Kaye S, Chalmers J, Sara G, Dobbins T, Burns L, Farrell M.

Int J Drug Policy. 2016 Dec;38:16-20. doi: 10.1016/j.drugpo.2016.10.018. Epub 2016 Nov 11.

PMID:
27842249
39.

Cryptosporidiosis Risk in New Zealand Children Under 5 Years Old is Greatest in Areas with High Dairy Cattle Densities.

Lal A, Dobbins T, Bagheri N, Baker MG, French NP, Hales S.

Ecohealth. 2016 Dec;13(4):652-660. Epub 2016 Oct 20.

PMID:
27766441
40.

Increasing Incidence of Salmonella in Australia, 2000-2013.

Ford L, Glass K, Veitch M, Wardell R, Polkinghorne B, Dobbins T, Lal A, Kirk MD.

PLoS One. 2016 Oct 12;11(10):e0163989. doi: 10.1371/journal.pone.0163989. eCollection 2016.

41.

A Psycho-Educational Intervention for People with a Family History of Depression: Pilot Results.

Meiser B, Peate M, Levitan C, Mitchell PB, Trevena L, Barlow-Stewart K, Dobbins T, Christensen H, Sherman KA, Dunlop K, Schofield PR.

J Genet Couns. 2017 Apr;26(2):312-321. doi: 10.1007/s10897-016-0011-5. Epub 2016 Sep 29.

PMID:
27688164
42.

Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data.

Joshi V, Adelstein BA, Schaffer A, Srasuebkul P, Dobbins T, Pearson SA; Elements of Cancer Care (EoCC) Investigators.

Asia Pac J Clin Oncol. 2017 Oct;13(5):e246-e252. doi: 10.1111/ajco.12602. Epub 2016 Sep 26.

PMID:
27665738
43.

Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary study.

Peacock A, Bruno R, Larance B, Lintzeris N, Nielsen S, Ali R, Dobbins T, Degenhardt L.

Drug Alcohol Depend. 2016 Sep 1;166:125-33. doi: 10.1016/j.drugalcdep.2016.07.003. Epub 2016 Jul 16.

PMID:
27430400
44.

Crystalline methamphetamine use and methamphetamine-related harms in Australia.

Degenhardt L, Sara G, McKetin R, Roxburgh A, Dobbins T, Farrell M, Burns L, Hall WD.

Drug Alcohol Rev. 2017 Mar;36(2):160-170. doi: 10.1111/dar.12426. Epub 2016 Jun 11.

PMID:
27286742
45.

Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated.

Gisev N, Pearson SA, Blanch B, Larance B, Dobbins T, Larney S, Degenhardt L.

Br J Clin Pharmacol. 2016 Oct;82(4):1123-33. doi: 10.1111/bcp.13026. Epub 2016 Jul 18.

46.

Associations of Housing First Configuration and Crime and Social Connectedness Among Persons With Chronic Homelessness Histories.

Whittaker E, Flatau PR, Swift W, Dobbins TA, Burns L.

Psychiatr Serv. 2016 Oct 1;67(10):1091-1097. Epub 2016 Jun 1.

PMID:
27247176
47.

A bedside test for methaemoglobinemia improved antidote use in propanil poisoning.

Shihana F, Dawson AH, Dobbins T, Dissanayake D, Buckley NA.

Clin Toxicol (Phila). 2016 Aug;54(7):576-80. doi: 10.1080/15563650.2016.1177651. Epub 2016 May 19.

PMID:
27196813
48.

Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014.

Degenhardt L, Larney S, Chan G, Dobbins T, Weier M, Roxburgh A, Hall WD, McKetin R.

Med J Aust. 2016 Mar 7;204(4):153.

PMID:
26937668
49.

KContact, an enhanced intervention for contact between children in out-of-home care and their parents: protocol for a cluster randomised controlled trial.

Taplin S, Bullen T, McArthur M, Humphreys C, Kertesz M, Dobbins T.

BMC Public Health. 2015 Nov 16;15:1134. doi: 10.1186/s12889-015-2461-3.

50.

A record linkage study of antidepressant medication use and weight change in Australian adults.

Paige E, Korda R, Kemp-Casey A, Rodgers B, Dobbins T, Banks E.

Aust N Z J Psychiatry. 2015 Nov;49(11):1029-39. doi: 10.1177/0004867415607365. Epub 2015 Oct 1.

PMID:
26427511

Supplemental Content

Loading ...
Support Center